New strategies for providing hormonal contraception in developing countries

Contraception

Volumn 83, Issue 5, 2011, Pages 405-409

  Townsend, John W ^a   Sitruk Ware, Regine ^a   Williams, Katherine ^a   Askew, Ian ^b   Brill, Klaus ^c  

^a POPULATION COUNCIL   (United States)

^b POPULATION COUNCIL   (Kenya)

^c BAYER PHARMA AG   (Germany)

Author keywords

Hormonal contraception; Implants; Injectables; Levonorgestrel intrauterine system; Oral contraceptive

Indexed keywords

CONTRACEPTIVE AGENT;

EVIDENCE BASED PRACTICE; FAMILY PLANNING; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HORMONAL CONTRACEPTION; HUMAN; REPRODUCTIVE HEALTH; REVIEW;

CONTRACEPTION; CONTRACEPTION BEHAVIOR; CONTRACEPTIVES, ORAL, HORMONAL; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; EVIDENCE-BASED PRACTICE; FAMILY PLANNING SERVICES; FEMALE; HUMANS; MALE; REPRODUCTIVE MEDICINE;

EID: 79954418474     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.08.015     Document Type: Review

References (22)

1. World Bank. Population Issues in the 21st Century: The Role of the World Bank. Washington, DC: The World Bank; 2009.
2. Population Reference Bureau (PRB). World Population Data Sheet. Washington, DC: Population Reference Bureau; 2009.
3. World Health Organization (WHO). Managing Contraceptive Products: Requirements for the Quality Assurance of Hormonal Contraception. Geneva: Human Reproduction Program; 1995.
4. Population Reference Bureau (PRB). World Population Data Sheet, Washington, DC: Population Reference Bureau; 2007.
5. Ramchandran D, Salem RM. New Findings on Contraceptives, Population Reports, Series M, No. 20 INFO Project. Baltimore (MD): Johns Hopkins Bloomberg School of Public Health; 2008.
6. World Health Organization (WHO) Department of Reproductive Health and Research (WHO/RHR), Johns Hopkins Bloomberg School of Public Health/ Center for Communication Programs (CCP). Family Planning: A Global Handbook for Providers. Baltimore, MD, and Geneva: CCP and WHO; 2008.
7. United Nations Population Fund (UNFPA). Achieving the ICPD Goals: Reproductive Health Commodity Requirements. New York: UNFPA; 2005.
8. Reproductive Health Supplies Coalition. Available at: http://www. rhsupplies.org. 2010.
9. United Nations (UN) Department of Economic and Social Affairs, Population Division. World Population Policies. New York: UN; 2007. p. 14.
10. Abt. Associates. PSP-One Project. Available at: http://www.psp-one. com/. 2010.
11. United Nations (UN) Department of Economic and Social Affairs, Population Division. State of the World Population 2007: Unleashing the Potential of Urban Growth. New York: UN; 2007.
12. Mohllajee AP, Curtis KM, Flanagan RG, Rinehart W, Gaffield ML, Peterson HB. Keeping up with evidence: a new system for WHO's evidence-based family planning guidance. Am J Preven Med 2005;28: 483-90. (Pubitemid 40723585)
13. Grimes DA. The safety of oral contraceptives: epidemiologic insights from the first 30 years. Am J Obstet Gynecol 1992;166(6, Part 2): 1950-4.
14. UNAIDS and UNFPA. Making condoms work for HIV prevention: cutting-edge perspectives. Geneva: UNAIDS Best-Practice Collection; 2004. p. 17.
15. Vujivic M, Ohiri K, Sparkes S. Working in Health: Managing and Financing the Public Sector Health Workforce. Washington, DC: World Bank; 2009.
16. Rosenfield AG, Limcharoen C. Auxiliary midwife prescription of oral contraceptives: An experimental project in Thailand. Am J Obstet Gynecol 1972;114:942-9.
17. World Health Organization (WHO), U.S. Agency for International Development (USAID), Family Health International (FHI). Community- based health workers can safely and effectively administer injectable contraceptives: conclusions from a technical consultation. Research Triangle Park, NC: FHI; 2009, p. 1-4.
18. World Health Organization (WHO) Human Reproductive Program. Community-Based Distribution of Contraceptives. Geneva: WHO Human Reproduction Program; 1995.
19. Mueter J. Social Franchising. Berlin Institut. Das Online-Handbuch Demografie. Berlin, Germany: Berlin Institut; 2008. Accessed at: http://www.berlin-institut.org. on October 1, 2009.
20. Bayer Schering Pharma (BSP) AG, News Release, 18 August 2009. BSP: Berlin, Germany.
21. International Contraceptive Access (ICA) Foundation. Available at: http://www.ica-foundation.org. 2010.
22. Family Health International (FHI). Sino-Implant (II). Accessed at: http://www.fhi.org/en/Research/Projects/sinoimplant.htm#. 2009 on October 1, 2009.